Pharmaceutical composition for prevention and treatment of mental disease with enhanced nmdar function
AssigneesInstitute for Basic Science, Korea Advanced Institute of Science and Technology
InventorsEun-Joon KIM, Su-Yeon CHOI, Wook-Suk CHUNG, Eun-Ee LEE, Ha-Ram PARK
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition for improving a sociability behavior in a patient having a mental disease with an enhanced NMDAR function.
Claims20
A method for treating a mental disease having enhanced N-methyl-D-aspartate (NMDA) receptor (NMDAR) function in a patient having the mental disease, the method comprising:
- administering an NMDAR inhibitor composition to the patient.
A method for decreasing enhanced N-methyl-D-aspartate (NMDA) receptor (NMDAR) function in a patient having enhanced NMDAR function, the method comprising:
- administering an NMDAR inhibitor composition to the patient.
A method for treating schizophrenia or attention deficit/hyperactivity disorder (ADHD) in a patient having schizophrenia or attention deficit/hyperactivity disorder (ADHD) and enhanced N-methyl-D-aspartate (NMDA) receptor (NMDAR) function, comprising:
- administering an NMDAR inhibitor composition to the patient.
Dependencies are inferred from the claim text.